Table of Contents Author Guidelines Submit a Manuscript
Spectroscopy: An International Journal
Volume 27 (2012), Article ID 176937, 10 pages
http://dx.doi.org/10.1155/2012/176937

Synchrotron FTIR Microspectroscopy Study of the Striatum in 6-Hydroxydopamine Rat Model of Parkinson's Disease

1Laboratory of Neuropharmacology and Neurotoxicology, School of Life Sciences, Shanghai University, Nanchen Road 333, Shanghai 200436, China
2Shanghai Key Laboratory of Special Artificial Microstructure Materials and Technology, Physics Department, Tongji University, Shanghai 200092, China
3National Synchrotron Radiation Laboratory, USTC, Hefei 230026, China

Copyright © 2012 Zhu Hongyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Braak, E. Braak, D. Yilmazer, C. Schultz, R. A. I. De Vos, and E. N. H. Jansen, “Nigral and extranigral pathology in Parkinson's disease,” Journal of Neural Transmission, Supplement, no. 46, pp. 15–31, 1995. View at Google Scholar · View at Scopus
  2. L. S. Forno, “Neuropathology of Parkinson's disease,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 3, pp. 259–272, 1996. View at Google Scholar · View at Scopus
  3. R. Betarbet, T. B. Sherer, D. A. Di Monte, and J. T. Greenamyre, “Mechanistic approaches to Parkinson's disease pathogenesis,” Brain Pathology, vol. 12, no. 4, pp. 499–510, 2002. View at Google Scholar · View at Scopus
  4. O. Blin, C. Desnuelle, O. Rascol et al., “Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy,” Journal of the Neurological Sciences, vol. 125, no. 1, pp. 95–101, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. Cassarino, C. P. Fall, R. H. Swerdlow et al., “Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease,” Biochimica et Biophysica Acta, vol. 1362, no. 1, pp. 77–86, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. R. E. Heikkila, P. K. Sonsalla, and R. C. Duvoisin, 12, 351–384, 1989.
  7. C. Sachs and G. Jonsson, “Mechanisms of action of 6-hydroxydopamine,” Biochemical Pharmacology, vol. 24, no. 1, pp. 1–8, 1975. View at Google Scholar · View at Scopus
  8. R. L. Faull and R. Laverty, “Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra,” Experimental Neurology, vol. 23, no. 3, pp. 332–340, 1969. View at Google Scholar · View at Scopus
  9. A. S. Perumal, V. B. Gopal, W. K. Tordzro, T. B. Cooper, and J. L. Cadet, “Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain,” Brain Research Bulletin, vol. 29, no. 5, pp. 699–701, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Petibois and G. Déléris, “Chemical mapping of tumor progression by FT-IR imaging: towards molecular histopathology,” Trends in Biotechnology, vol. 24, no. 10, pp. 455–462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. W. D. Duncan and Gwyn P. Williams, “Infrared synchrotron radiation from electron storage rings,” Applied Optics, vol. 22, no. 18, pp. 2914–2923, 1983. View at Google Scholar · View at Scopus
  12. G. L. Carr, J. A. Reffner, and G. P. Williams, “Performance of an infrared microspectrometer at the NSLS,” Review of Scientific Instruments, vol. 66, no. 2, pp. 1490–1492, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. L. M. Miller and R. J. Smith, “Synchrotrons versus globars, point-detectors versus focal plane arrays: selecting the best source and detector for specific infrared microspectroscopy and imaging applications,” Vibrational Spectroscopy, vol. 38, no. 1-2, pp. 237–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Chen and C. P. Tripp, “An infrared spectroscopic based method to measure membrane permeance in liposomes,” Biochimica et Biophysica Acta, vol. 1778, no. 10, pp. 2266–2272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Chwiej, J. Dulinska, K. Janeczko et al., “Synchrotron FTIR micro-spectroscopy study of the rat hippocampal formation after pilocarpine-evoked seizures,” Journal of Chemical Neuroanatomy, vol. 40, no. 2, pp. 140–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Petibois and G. Déléris, “Evidence that erythrocytes are highly susceptible to exercise oxidative stress: FT-IR spectrometric studies at the molecular level,” Cell Biology International, vol. 29, no. 8, pp. 709–716, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Fabian and D. Naumann, “Methods to study protein folding by stopped-flow FT-IR,” Methods, vol. 34, no. 1, pp. 28–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Petibois, G. Cazorla, A. Cassaigne, and G. Déléris, “Plasma protein contents determined by fourier-transform infrared spectrometry,” Clinical Chemistry, vol. 47, no. 4, pp. 730–738, 2001. View at Google Scholar · View at Scopus
  19. B. Mohlenhoff, M. Romeo, M. Diem, and B. R. Wood, “Mie-type scattering and non-Beer-Lambert absorption behavior of human cells in infrared microspectroscopy,” Biophysical Journal, vol. 88, no. 5, pp. 3635–3640, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. L. P. Choo, D. L. Wetzel, W. C. Halliday, M. Jackson, S. M. LeVine, and H. H. Mantsch, “In situ characterization of β-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy,” Biophysical Journal, vol. 71, no. 4, pp. 1672–1679, 1996. View at Google Scholar · View at Scopus
  21. L. M. Miller, Q. Wang, T. P. Telivala, R. J. Smith, A. Lanzirotti, and J. Miklossy, “Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease,” Journal of Structural Biology, vol. 155, no. 1, pp. 30–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Y. Huang, L. M. Miller, C. S. Carlson, and M. R. Chance, “Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment,” Bone, vol. 30, no. 3, pp. 492–497, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Kneipp, P. Lasch, E. Baldauf, M. Beekes, and D. Naumann, “Detection of pathological molecular alterations in scrapie-infected hamster brain by Fourier transform infrared (FT-IR) spectroscopy,” Biochimica et Biophysica Acta, vol. 1501, no. 2-3, pp. 189–199, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Kneipp, L. M. Miller, M. Joncic et al., “In situ identification of protein structural changes in prion-infected tissue,” Biochimica et Biophysica Acta, vol. 1639, no. 3, pp. 152–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. M. Gough, D. Zelinski, R. Wiens, M. Rak, and I. M. C. Dixon, “Fourier transform infrared evaluation of microscopic scarring in the cardiomyopathic heart: effect of chronic AT1 suppression,” Analytical Biochemistry, vol. 316, no. 2, pp. 232–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. Miller and P. Dumas, “Chemical imaging of biological tissue with synchrotron infrared light,” Biochimica et Biophysica Acta, vol. 1758, no. 7, pp. 846–857, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Szczerbowska-Boruchowska, P. Dumas, M. Z. Kastyak et al., “Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy,” Archives of Biochemistry and Biophysics, vol. 459, no. 2, pp. 241–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Ruiperez, F. Dariosand, and B. Davletov, Prog Lipid Res, 49, 420–428.
  29. A. A. Farooqui and L. A. Horrocks, “Lipid peroxides in the free radical pathophysiology of brain diseases,” Cellular and Molecular Neurobiology, vol. 18, no. 6, pp. 599–608, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Waldbaum and M. Patel, “Mitochondria, oxidative stress, and temporal lobe epilepsy,” Research, vol. 88, no. 1, pp. 23–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Jenner, “Oxidative stress in Parkinson's disease,” Annals of Neurology, vol. 53, supplement 53, pp. S26–S36, 2003. View at Google Scholar
  32. J. Lotharius and P. Brundin, “Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein,” Nature Reviews. Neuroscience, vol. 3, no. 12, pp. 932–942, 2002. View at Google Scholar · View at Scopus
  33. J. Bandekar, “Amide modes and protein conformation,” Biochimica et Biophysica Acta, vol. 1120, no. 2, pp. 123–143, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Krimm and J. Bandekar, “Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins,” Advances in Protein Chemistry, vol. 38, no. C, pp. 181–364, 1986. View at Publisher · View at Google Scholar · View at Scopus
  35. D. M. Byler and H. Susi, “Examination of the secondary structure of proteins by deconvolved FTIR spectra,” Biopolymers, vol. 25, no. 3, pp. 469–487, 1986. View at Google Scholar · View at Scopus
  36. H. Susi and D. M. Byler, “Protein structure by Fourier transform infrared spectroscopy: second derivative spectra,” Biochemical and Biophysical Research Communications, vol. 115, no. 1, pp. 391–397, 1983. View at Google Scholar · View at Scopus
  37. C. A. Ross and M. A. Poirier, “Protein aggregation and neurodegenerative disease,” Nature Medicine, vol. 10, pp. S10–S17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. A. T. Welzel and D. M. Walsh, “Aberrant protein structure and diseases of the brain,” Irish Journal of Medical Science, vol. 180, no. 1, pp. 15–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Factor and W. Weiner, Eds., Parkinson's Disease: Diagnosis and Clinical Management, Demos Medical, New York, NY, USA, 2002.